Anthony F. Shields

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

Edward S. Kim, R. Goldberg, H. Lenz, 2020, International journal of cancer.

Expression of Inflammatory Modulator COX-2 in Pancreatic Ductal Adenocarcinoma and Its Relationship to Pathologic and Clinical Parameters

D. Grignon, F. Sarkar, P. Philip, 2001, American journal of clinical oncology.

Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo.

A. Shields, J. Grierson, J R Grierson, 2000, Nuclear medicine and biology.

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials

S. Lonardi, A. Sobrero, I. Souglakos, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells

S. Modak, M. Yankelevich, A. Thakur, 2024, Journal for ImmunoTherapy of Cancer.

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

H. Mamdani, D. Spetzler, K. Poorman, 2024, Cancer research communications.